✦ LIBER ✦

The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis

✍ Scribed by A. Campanati, G. Ganzetti, A. Di Sario, A. Damiani…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin-related biomarkers and their rel

✍ Tomoyuki Kawada 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 90 KB

THE PREVALENCE OF METABOLIC SYNDROME (MS

✍ Dafni Koumoutsea; Ioannis Karydis; Panagiota Thalassinou; Damianos Aslanoglou; P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Sa1050 Prevalence and Risk Factors of No

✍ Phisalprapa, Pochamana; Ujjin, Anunya; Apisarnthanarak, Piyaporn; Charoensak, Ap 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Sa1055 Use of Insulin and Sulfonylurea I

✍ Goh, George Boon-Bee; Dasarathy, Jaividhya; Pagadala, Mangesh R.; Unalp, Aynur; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Tu1036 The Cirrhosis Risk Score is Not A

✍ Shen, Jiayun; Chan, Henry Lik-Yuen; Wong, Grace; Chan, Anthony Wing-Hung; Chan, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Effects of nuclear receptor FXR on the r

✍ Zhao-Xia Yang; Wei Shen; Hang Sun 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 515 KB